SCHEMBL18200412

SCHEMBL18200412

c1ccc2c(-c3nc(-c4ccc(-c5nc6ccccc6c6c5ccc5ccccc56)cc4)nc4ccccc34)cccc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 3/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
ALDH1A1 P00352 6/20 0.39
KDM4E B2RXH2 4/20 0.39
MAPT P10636 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TP53 P04637 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
NFKB1 P19838 1/20 0.39
MAPK1 P28482 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18200594 0.99 ATM (0.50) ATMMEN1KMT2AALDH1A1KDM4E
SCHEMBL18200943 0.92 ATM (0.46) ATMMEN1KMT2AALDH1A1KDM4E
SCHEMBL18201123 0.92 MEN1 (0.46) ATMMEN1KMT2AALDH1A1KDM4E
SCHEMBL18346961 0.91 MEN1 (0.61) ATMMEN1KMT2AALDH1A1KDM4E
SCHEMBL18200411 0.91 MEN1 (0.61) ATMMEN1KMT2AALDH1A1KDM4E
SCHEMBL18200381 0.90 MEN1 (0.43) ATMMEN1KMT2AALDH1A1KDM4E
SCHEMBL18200388 0.90 ATM (0.46) ATMMEN1KMT2AALDH1A1KDM4E
SCHEMBL18200496 0.90 ATM (0.47) ATMMEN1KMT2AALDH1A1KDM4E
SCHEMBL18201205 0.89 MEN1 (0.60) ATMMEN1KMT2AALDH1A1KDM4E
SCHEMBL18201112 0.89 MEN1 (0.60) ATMMEN1KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 ATM 2923/4885MEN1 1750/4885KMT2A 1104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.